Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Mit dieser Aktie könntest Du von der Cannabis-Legalisierungswelle profitieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QA1Y | ISIN: US0051111096 | Ticker-Symbol:
NASDAQ
08.05.24
22:00 Uhr
0,090 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ACUTUS MEDICAL INC Chart 1 Jahr
5-Tage-Chart
ACUTUS MEDICAL INC 5-Tage-Chart

Aktuelle News zur ACUTUS MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrAcutus Medical, Inc. - 8-K, Current Report1
16.05.NSE - Acutus Medical, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities1
15.05.Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. from The Nasdaq Stock Market94NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of Better Therapeutics, Inc. Better Therapeutics, Inc.'s securities were suspended...
► Artikel lesen
09.05.Acutus Medical delisted from Nasdaq market due to non-compliance2
06.05.Why Is Acutus Medical (AFIB) Stock Down 41% Today?3
03.05.Acutus Medical, Inc. - 8-K, Current Report2
01.04.Acutus Medical GAAP EPS of -$2.81, revenue of $7.2M1
01.04.Acutus Medical, Inc. - 10-K, Annual Report1
01.04.Acutus Medical, Inc. - 8-K, Current Report1
08.02.Acutus Medical, Inc. - 8-K, Current Report1
11.01.Acutus Medical, Inc. - 8-K, Current Report4
08.11.23Acutus Medical, Inc.: Acutus Medical Announces Strategic Realignment of Resources and Corporate Restructuring257CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), today announced a realignment of resources and corporate restructuring. Scott Huennekens...
► Artikel lesen
08.11.23Acutus Medical, Inc.: Acutus Medical Reports Third Quarter 2023 Financial Results164CARLSBAD, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB) today reported results for the third quarter of 2023. Recent Highlights: Third quarter...
► Artikel lesen
02.11.23Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)148CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
► Artikel lesen
02.10.23Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)169CARLSBAD, Calif., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
► Artikel lesen
07.08.23Acutus Medical, Inc.: Acutus Medical Reports Second Quarter 2023 Financial Results208CARLSBAD, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
► Artikel lesen
01.08.23Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)209CARLSBAD, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
► Artikel lesen
03.07.23Acutus Medical, Inc.: Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)307CARLSBAD, Calif., July 03, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. ("Acutus" or the "Company") (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1